Dr. Richard Graham
Advertisement
Dr. Richard Graham is chairman of the board at Tru Technologies.
Articles by Dr. Richard Graham
Dr. Richard Graham discusses the distinction between real-time data and real-time oversite and how one option may present better results than the other.
Dr. Richard Graham details how real-time data review may reduce timelines but also allow for bad data or outcomes.
Dr. Richard Graham explains how FDA’s new program allows for the usage of real-time data during clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
The Industry's Interest in Vaccine Platforms
5